
Voranigo (vorasidenib)
Voranigo is a brand-name oral tablet prescribed for certain brain tumors. Voranigo contains the active ingredient vorasidenib. Specifically, the Food and Drug Administration (FDA) has approved Voranigo to treat grade 2 astrocytomas and oligodendrogliomas …